Opthea Limited (NASDAQ:OPT - Get Free Report)'s stock price gapped up prior to trading on Thursday . The stock had previously closed at $4.41, but opened at $4.80. Opthea shares last traded at $4.62, with a volume of 11,126 shares.
Wall Street Analyst Weigh In
Separately, Canaccord Genuity Group upgraded Opthea to a "strong-buy" rating in a report on Tuesday, December 17th.
Get Our Latest Research Report on Opthea
Opthea Stock Performance
The firm's 50 day moving average is $3.61 and its two-hundred day moving average is $3.44.
Institutional Trading of Opthea
A hedge fund recently bought a new stake in Opthea stock. Twin Lakes Capital Management LLC acquired a new position in shares of Opthea Limited (NASDAQ:OPT - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 19,806 shares of the company's stock, valued at approximately $81,000. Institutional investors own 55.95% of the company's stock.
Opthea Company Profile
(
Get Free Report)
Opthea Limited, a clinical stage biopharmaceutical company, engages in the development and commercialization of therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.
See Also
Before you consider Opthea, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Opthea wasn't on the list.
While Opthea currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
